These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24905979)

  • 1. Construction and expression of a novel anti-CD14 human-mouse chimeric antibody Hm2F9.
    Shen DY; Ning BT; Tang YM; Li SS
    DNA Cell Biol; 2014 Sep; 33(9):599-604. PubMed ID: 24905979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and expression of single-chain antibody derived from a new clone of monoclonal antibody against human CD14 in CHO cells.
    Tang YM; Ning BT; Cao J; Shen HQ; Qian BQ
    Immunopharmacol Immunotoxicol; 2007; 29(3-4):375-86. PubMed ID: 18075851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eukaryotic expression and determination of ZCH-7-2F9 single chain antibody against human CD14].
    Ning BT; Tang YM; Cao J; Shen HQ; Qian BQ
    Zhonghua Er Ke Za Zhi; 2008 Aug; 46(8):605-9. PubMed ID: 19099834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells.
    Cao M; Cao P; Yan H; Lu W; Ren F; Hu Y; Zhang S
    Appl Biochem Biotechnol; 2009 Jun; 157(3):562-74. PubMed ID: 19099209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen.
    Bose B; Khanna N; Acharya SK; Sinha S
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful construction and massive expression of a novel Anti-CD19 human-mouse chimeric antibody Hm2E8b.
    Shen D; Tang Y; Li S; Xu W; Zhang L
    Monoclon Antib Immunodiagn Immunother; 2014 Aug; 33(4):215-20. PubMed ID: 25171000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
    Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
    Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding activity difference of anti-CD20 scFv-Fc fusion protein derived from variable domain exchange.
    Geng SS; Feng J; Li Y; Sun Y; Gu X; Huang Y; Wang Y; Kang X; Chang H; Shen B
    Cell Mol Immunol; 2006 Dec; 3(6):439-43. PubMed ID: 17257497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and expression of human scFv-Fc against interleukin-33.
    Ye Y; Nian S; Xu W; Wu T; Wang X; Gao Y; Yuan Q
    Protein Expr Purif; 2015 Oct; 114():58-63. PubMed ID: 26112138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal half of membrane CD14 is a functional cellular lipopolysaccharide receptor.
    Viriyakosol S; Kirkland TN
    Infect Immun; 1996 Feb; 64(2):653-6. PubMed ID: 8550221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
    Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
    J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influencedby endotoxin concentration.
    Triantafilou M; Triantafilou K; Fernandez N
    Eur J Biochem; 2000 Apr; 267(8):2218-26. PubMed ID: 10759844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stable expression of human anti-IL-33 scFv-IgG1Fc fusion protein in CHO k1 cells].
    Ye Y; Nian S; Wang X; Wu T; Xu W; Yuan Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):600-3, 608. PubMed ID: 27126936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glycosylation of anti-rhIFN-α2b recombinant antibodies influences the antigen-neutralizing activity.
    Attallah C; Aguilar MF; Forno G; Etcheverrigaray M; Brigido MM; Maranhão AQ; Oggero M
    Biotechnol Lett; 2020 Aug; 42(8):1369-1381. PubMed ID: 32285235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and expression of prokaryotic vector of single chain antibody derived from a new clone of anti-CD14 antibody ZCH-7-2F9].
    Ning BT; Tang YM; Cao J; Shen HQ; Qian BQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 37(1):51-9. PubMed ID: 18275120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity.
    Delude RL; Fenton MJ; Savedra R; Perera PY; Vogel SN; Thieringer R; Golenbock DT
    J Biol Chem; 1994 Sep; 269(35):22253-60. PubMed ID: 7520914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A region of human CD14 required for lipopolysaccharide binding.
    Viriyakosol S; Kirkland TN
    J Biol Chem; 1995 Jan; 270(1):361-8. PubMed ID: 7529231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction events in Chinese hamster ovary cells expressing human CD14; effect of endotoxin desensitization.
    Ferlito M; Squadrito F; Halushka PV; Cook JA
    Shock; 2001 Apr; 15(4):291-6. PubMed ID: 11303728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans.
    Verbon A; Dekkers PE; ten Hove T; Hack CE; Pribble JP; Turner T; Souza S; Axtelle T; Hoek FJ; van Deventer SJ; van der Poll T
    J Immunol; 2001 Mar; 166(5):3599-605. PubMed ID: 11207321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide.
    Preston MJ; Gerçeker AA; Reff ME; Pier GB
    Infect Immun; 1998 Sep; 66(9):4137-42. PubMed ID: 9712759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.